Synthetic Biology News

Learn how a new Claudin 6 CAR T immunotherapy strategy leverages a Claudin6 mRNA nanoparticle vaccine to boost the efficacy of cell therapy against solid tumors.

Learn about a new cell therapy strategy under clinical evaluation that leverages Cardiosphere-derived cells (CDCs) to reduce the progression of cardiac and skeletal myopathy in DMD patients.

Advancing mRNA Medicines: Progressing Beyond Vaccines to Immunotherapies

NGS has reduced cost and accelerated DNA sequencing, but Sanger sequencing continues to be ideal for routine low volume synthetic DNA and plasmid sequencing.

Learn about GenScript’s manufacturing facility in the USA, which will offer fully automated gene synthesis and sequencing services.

At St. Jude Children’s Hospital, scientists used an integrated sequencing platform to understand genomic variants associated with a broad range of pediatric cancer types.

Learn about a new CRISPR/Cas9 application leveraging its RNA guided specificity to self-assemble peptide fused and inactivated Cas9 onto DNA microarrays.

Learn how AAV2-hAADC gene therapy targeting dopamine neurons in the midbrain allowed restoring motor function in AADC patients.

Learn how lentiviral vectors promise to offer a safer gene delivery approach for correction of immunological deficits in SCID-ADA.

Learn how an influenza hemagglutinin nanoparticle vaccine protects against influenza viral strains by inducing broad neutralizing antibodies.